Remove Biochemical Assays Remove Cell Based Assays Remove Drug Development
article thumbnail

Article FDA Thank You Draft guidance on potency assays for CGT products garners extensive stakeholder input

Agency IQ

For example, in describing how potency should be demonstrated for CGT products, the 2011 guidance simply stated that potency for gene therapy products is derived from β€œat least two biological activities for its potency: the ability to transfer a genetic sequence to a cell; and the biological effect of the expressed genetic sequence.”

article thumbnail

Transforming high-throughput screening with mass spectrometry

Drug Discovery World

HTS as a tool for drug discovery has evolved rapidly since the origin of the technique in the 1990s. Trapped ion mobility spectrometry: Improving the specificity of MALDI-MS-based HTS . Wagner, MALDI imaging mass spectrometry: Bridging biology and chemistry in drug development, Bioanalysis, 2011, 3: 2427–2441, [link].